Literature DB >> 9589707

Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma.

M Cellini1, G L Possati, V Profazio, M Sbrocca, N Caramazza, R Caramazza.   

Abstract

Endothelin-1 (ET-1) is a potent vasoconstrictor peptide produced by vascular endothelin cells There are reports in the literature that ET-1 plasma levels are raised in low tension glaucoma (LTG). ET-1 plasma concentration and Color Doppler Imaging (CDI) evaluation in ophthalmic and posterior ciliary arteries were measured in 15 LTG patients and in 15 healthy subjects. The blood flow index recorded for the ophthalmic artery in normal subjects was a PSV of 36.646 +/- 6.611 cm/sec with RI of 0.717 +/- 0.019 while in the LTG patients it was 32.961 +/- 3.045 cm/sec (p < 0.003) with RI of 0.789 +/- 0.018 (p < 0.001). For the posterior ciliary arteries in the same two groups, we obtained a PSV of 13.878 +/- 4.149 cm/sec vs 8.720 +/- 1.645 cm/sec (p < 0.001) and an RI of 0.679 +/- 0.039 vs 0.722 +/- 0.024 (p < 0.001). The plasma ET-1 level in normal subjects was 1.720 +/- 0.174 pg while in LTG patients it was 2.947 +/- 0.217 pg (p < 0.001). On the basis of our experience, we think that GON and the visual field damage found in LTG can be attributed to an alteration in the endothelial self-regulating sections and consequent vascular insufficiency, particularly pronounced in the posterior ciliary arteries which, since it is these that provide the blood supply to the optic nerve head, leads to irreversible functional damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9589707     DOI: 10.1111/j.1600-0420.1997.tb00448.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand Suppl        ISSN: 1395-3931


  27 in total

1.  Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma.

Authors:  M Emre; S Orgül; T Haufschild; S G Shaw; J Flammer
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

Review 2.  Age-related ocular vascular changes.

Authors:  Rita Ehrlich; Nisha S Kheradiya; Diana M Winston; Daniel B Moore; Barbara Wirostko; Alon Harris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-16       Impact factor: 3.117

3.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

4.  Differences in corneal parameters between normal tension glaucoma and primary open-angle glaucoma.

Authors:  Jacky W Y Lee; Raymond L M Wong; Jonathan C H Chan; Ian Y H Wong; Jimmy S M Lai
Journal:  Int Ophthalmol       Date:  2014-11-25       Impact factor: 2.031

Review 5.  Endothelin, astrocytes and glaucoma.

Authors:  Ganesh Prasanna; Raghu Krishnamoorthy; Thomas Yorio
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

6.  Black currant anthocyanins normalized abnormal levels of serum concentrations of endothelin-1 in patients with glaucoma.

Authors:  Kaori Yoshida; Ikuyo Ohguro; Hiroshi Ohguro
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-21       Impact factor: 2.671

Review 7.  Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis.

Authors:  H E Killer; A Pircher
Journal:  Eye (Lond)       Date:  2018-02-19       Impact factor: 3.775

8.  Effects of erytropoietin treatment and hemodialysis on the serum endothelin level and intraocular pressure of hemodialysis patients.

Authors:  Remzi Karadag; Ramazan Yagci; Bahri Aydin; Mehmet Kanbay; Mesut Erdurmus; Ugur Can Keskin; Ali Akcay; Mustafa Durmus
Journal:  Int Ophthalmol       Date:  2008-07-19       Impact factor: 2.031

Review 9.  Eyeing endothelins: a cellular perspective.

Authors:  Ganesh Prasanna; Santosh Narayan; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 10.  Current concepts in the pathophysiology of glaucoma.

Authors:  Renu Agarwal; Suresh K Gupta; Puneet Agarwal; Rohit Saxena; Shyam S Agrawal
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.